In the same study, bone marrow biopsy specimens of myeloma patients with osteolytic lesions showed a markedly reduced number of Runx2/CBFA1 positive cells compared to those without myeloma bone disease [90,91]. The gene discussed is RUNX2; the disease is plasma cell myeloma.